Warning: This security is no longer trading.
PhaseRX was acquired by Roivant Sciences
PhaseRx, Inc. (PZRX): Price and Financial Metrics
PZRX Price/Volume Stats
| Current price | $0.28 | 52-week high | $1.95 |
| Prev. close | $0.31 | 52-week low | $0.22 |
| Day low | $0.28 | Volume | 1,044,200 |
| Day high | $0.34 | Avg. volume | 1,243,283 |
| 50-day MA | $0.51 | Dividend yield | N/A |
| 200-day MA | $0.80 | Market Cap | 3.27M |
PZRX Stock Price Chart Interactive Chart >
PhaseRx, Inc. (PZRX) Company Bio
PhaseRx, a preclinical biopharmaceutical company, develops RNA therapeutics for the treatment of orphan liver disease. The company was founded in 2006 and is headquartered in Seattle, Washington.
PZRX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...